Clinical Trials Logo
  1. Home
  2. Infant Growth
  3. NCT04306263

Effect of a New Infant Formula With Specific Ingredients — EARLY-TOLERA  

Infant Growth Clinical Trial

Official title:
Evaluation of the Effect of a New Infant Formula With Specific Ingredients on the Development of the Immune System and the Gastrointestinal Health of the Infant

Clinical Trial Summary

The purpose of this study is to test whether the addition of certain bioactive ingredients to a new infant formula (HMOs, osteopontin and probiotics) can have a favorable impact on the development of the infant's immune system in the first months of life.

Clinical Trial Description

Nowadays, almost all commercial infant formulas resemble the "gold standard" of breast milk in terms of composition of essential nutrients, but it is still a challenge to identify and incorporate certain bioactive components capable of replicating those stimuli typical of breast milk that can program growth, infant development and maturation of the immune system. The purpose of this study is to test whether the addition of certain bioactive ingredients to a new infant formula (HMOs, osteopontin and probiotics) can have a favorable impact on the development of the infant's immune system in the first months of life. In addition, considering that the quality of feeding at these early ages will program (Early programming) the health and physiology of the child and the future adult, the study wants to obtain evidence of the effects of this new infant formula on the immune system and the development of the child compared to breast milk during the first year of life, hoping that it promotes proper growth, adequate cognitive development and maturation of the immune system as similar as possible to children fed to the mother's breast. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04306263
Study type Interventional
Source Laboratorios Ordesa
Contact Roser De Castellar, MD
Phone 902 10 52 43
Email roser.decastellar@ordesa.es
Status Recruiting
Phase N/A
Start date March 2, 2020
Completion date September 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT06091917 - Modulating Early-life Nutrition for Childhood Obesity Prevention N/A
Completed NCT02111837 - Effects of Specific Lipid Fractions-enriched Infant Formulae N/A
Recruiting NCT05119166 - International Milk Composition (IMiC) Consortium
Completed NCT02142647 - Effect of Protein From Complementary Foods on Infant Growth, Body Composition and Gut Health N/A
Completed NCT00388141 - Nursing and Nurturing Premature Infants Phase 0
Completed NCT01084109 - First Bites: Complementary Feeding - A Global Network Cluster Randomized Controlled Trial Phase 3
Completed NCT02307760 - Evaluation of Human Milk Fortifiers in Preterm Infants N/A
Recruiting NCT03808207 - Human Milk Lipid Profile Assessment and Influences of Mother's Diet N/A
Completed NCT03993860 - Introduction of Fish Early in the Complementary Feeding Period to Improve Infant Growth N/A
Terminated NCT05804214 - Observational Study of Infants Fed With Dairy and Plant Based Infant Formula